JMT-103 shows safety and efficacy in phase Ib/II study in patients with giant cell tumor of bone June 7, 2021
New phase I/II study evaluates AGuIX gadolinium-based nanoparticles in pancreatic and lung cancers June 7, 2021
Enrollment begins in phase I study of RO-7300490 as single agent or in combination with atezolizumab June 7, 2021
BTK-selective degrader NX-5948 reduces inflammation in a murine model of rheumatoid arthritis June 7, 2021
Sorrento Therapeutics and Karolinska Institutet collaborate on iPSC-derived DAR-NK cells June 7, 2021
Boehringer Ingelheim initiates phase I study of BI-765049 alone or in combination with BI-754091 June 7, 2021
Genome-wide screening identifies shared and specific host factors of SARS-CoV-2 and other CoVs June 7, 2021
Localized production of protein therapeutics in tumor cells using the SHREAD gene therapy platform June 7, 2021
RSS